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hyoscyamin is not precisely the same as that of hyoscin(scopolamin), so that we must use a mean value or else
report our alkaloid in terms of hyoscyamin, or of atro¬
pin, which amount to the same thing.The polariscope can not aid us very much becauseboth hyoscyamin and hyoscin (scopolamin) are levo-
rotatory. There is one important difference probably.
Hyoscyamin combines with a larger proportion of
iodin than hyoscin under similar conditions. Possibly
this may serve to show approximately the relative pro¬
portion of the two alkaloids, but this is a suggestion
that must be worked out experimentally. Up to the
present time we certainly have no satisfactory way of
determining the therapeutic value of a sample of hen¬
bane, except by actual trial—the method that our
fathers had to use before us.
I speak of these things, not to belittle the value of
chemical assays. I am a firm believer in such assays. I
have full confidence that science will overcome the ob¬
stacles that seem now almost unsurmountable ; that the
day is not far distant, indeed, when the particular dif¬
ficulties which surround the assay of mydriatic drugs
will have been conquered. But this can only be hoped
for if we clearly understand the nature and the mag¬
nitude of the difficulties.
Recurring now to the tropeins as compounds of some
organic acid with tropin, I call attention to the peculiar
interest which attaches to the latter (basic) constituent
by reason of its relationship with the organic base
pyridin, and so with coniin and nicotin and with the
decomposition products of cocain. It will not be profit¬
able to enter here into the details of these relationships.
It suffices to know that modern organic chemistry is
rapidly mastering the intricacies of the molecular con¬
stitution of compounds so complex as the vegetable al¬
kaloids.
That this knowledge is not purely transcendental, but
capable of practical application, is proved by the fact
that the chemist is able not only to reconstruct from its
constituents, one of which he is able already to produce
synthetically, the alkaloid atropin, but also to form new
artificial alkaloids, one of which, homatropin, is already
 familiarly known as an article of the materia medica.Some of these synthetic alkaloids, as I have already said,
have a strong mydriatic action ; others little or none. A
wide field is opened for useful experiment on their
physiologic and possible therapeutic action.
Who shall pursue these researches and in what spirit
shall it be done? Many of them will lead only to neg¬
ative results. A few will lead to discoveries that will
enable us to cope successfully with morbid conditions
that now baffle our skill. Such rewards appeal to two
classes : to men on the one hand whose profession binds
them to unwearying, strenuous effort to possess them¬
selves of every resource for the ministering to human
needs; to men on the other hand who understand the
commercial value of a new popular medicine. Which
of these classes will be most likely to find the treasures
that lie hidden in these new mines? Which will make
such use of those treasures when found as will make the
world richest through them ?
The work, friends, is ours. To the toil it involves
our lives are consecrated. To us alone is known the
true value of the objects of this search. To us of right
belong the honor and the glory of discoveries such as we
hope for. It should be a shame to us to have to pay
tribute to the mercenary explorer who has adventured
more for gold than we for humanity—and the chance
is that any such tribute is after all bare-faced imposition.
It is not alone the glory, it is the work, that is ours—
patient, plodding, self-sacrificing toil, and the place
above all others to do that work is right here in the
Section on Materia Medica, Pharmacy and Thera¬
peutics of the American Medical Association. It is
our task ; it is also our glorious opportunity. Let us see
that the opportunity is improved.
THE PHYSIOLOGIC ACTION OF THE
MYDRIATIC ALKALOIDS.*
HORATIO C. WOOD, Jr., M.D.
Demonstrator of I'harmacodynamics, University of Pennsylvania.
PHILADELPHIA.
The number of drugs which dilate the pupil is so
very large, and the physiologic relations of many of
them so distant, that a consideration of all those sub¬
stances which might be called mydriatics would not only
consume much more time than is at our disposal, but
would necessitate classing together of drugs not natur¬
ally so related. I shall, therefore, confine my remarks
to those alkaloids which belong to the series of tropins;
and for similar reasons of brevity omit the considera¬
tion of the synthetic alkaloids of this series, such as
homatropin.
Before, however, taking up the consideration of thephysiologic action of these substances, I wish to call at¬
tention to the very unfortunate confusion in the nomen¬
clature of the active principles of the solanaceous
plants. As various investigators have from time to
time discovered in different members of this family al-
kaloidal principles, they have given new names to their
discoveries, which in many cases were subsequentlyfound to be identical with alkaloids already described.Thus, for example, the active principle of Datura stra¬
monium has been called daturin, it being in reality
atropin ; scopolin is synonymous with scopolamin ; whilethe active principle of Duboisia myropoiàes, known
sometimes as duboisin, seems to be a mixture of hyos¬
cin and hyoscyamin. There are four of these mydriatic
alkaloids occurring in Nature which have become of
practical importance to the physician: atropin, hyos¬
cin, hyoscyamin and s. ipolamin. These group them¬
selves naturally into two pairs, atropin and hyoscyamin,hyoscin and scopolamin.
ATEOPIN" AND HYOSCYAMIÍT.
As closely allied physiologically to atropin as it is
chemically is the isomerie alkaloid hyoscyamin. Thisis perhaps the most widely distributed of all the sola¬
naceous alkaloids; it occurs not only in both Atropabelladonna and Ilyoscyamus niger, but also in the Du¬boisia myropoides, Datura stramonium, and especially
in certain species of scopolia; while atropin is found
chiefly in belladonna and stramonium. The frequent
substitution of the rhizome of Scopolia carniolica, the
dominant alkaloid of which is hyoscyamin, for bella¬donna, renders the question of the comparative effect of
these principles of great importance.
It is to be noted that of these two plants belladonna
contains hyoscyamin and atropin, the latter being the
domina'nt alkaloid; while scopolia·contains hyoscyamin
and hyoscin. The amount of hyoscin, however, present in
the rhizome of Scopolia carniolica is so small as to have
little bearing on the physiologic action of this plant,
notwithstanding the contrary assertion sometimes made
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by interested manufacturers. (This statement does
not hold true of Scopolia atropoides, in which
the dominant alkaloid seems to be hyoscin.) In an in¬
vestigation which I made a year ago concerning thè re¬
lations of Scopolia carniolica to Atropa belladonna, I
was unable to detect any differences either between the
action of hyoscyamin and atropin, or between scopolia
and belladonna, except one of dose ; and what I shall say
of the action of atropin, therefore, applies also to hyos¬
cyamin.
In generalizing the physiologic action of atropin the
most characteristic effects seem to be a paralysis of theinvoluntary muscle fiber, a paralysis of the peripheral
nerve endings and a peculiar stimulation of some of the
higher nerve centers. The peripheral nerves which are
most susceptible to the action of this substance are the
cardiac inhibitors, the nerves regulating secretion and
those which supply the pupils. Since we have grouped
these drugs together on account of their action on the
eye it is logical to consider this portion of the subject
first.
Eyes.—Atropin has two effects on the eye : it dilates
the pupil and paralyzes accommodation. These actions,
although usually associated in the same drug, are not
so of necessity. A priori, there is no reason why a drug
might not either affect the pupil and leave intact the
ciliary muscle, or vice versa, paralyze accommodation
without alteration in the iris.
For the purpose of closer study of the manner in
which atropin dilates the pupil. I have prepared a dia¬
gram representing the innervation of the eye, which will
not only save a great deal of circumlocution, but per¬haps make the subject clearer than a lengthy descrip¬
tion. In the first place, we must remember that under
the only condition in which it is possible to examine the
eye, that is, in the presence of a certain amount of light,the sphincter pupilla? is always in a state of partial con¬
traction. It is evident, therefore, that a drug may dilate
the pupil, not only by stimulating the dilator mechan¬
ism, but also by paralyzing the contractor mechanism.
If we glance for a moment at the diagram we see that
these effects may be either on the .enters governing these
muscles, on the nerve trunks which carry the im¬pulses from the centers, or on the muscles themselves.
It is evident, therefore, that the pupil may be dilated,
on the one hand, either by stimulation of the sym¬pathetic ganglia, representing the dilator centers, or of
the nerve which carries the dilator impulses to the
muscle, or by a direct action on the radial fibers of the
iris. On the other hand, the pupil may be dilated byparalysis of the contractor mechanism, the oculomotor
centers in the brain, tìie oculomotor nerve which sup¬plies the sphincter pupilla, or, finally, by a direct influ¬
ence on this muscle.
That the dilatation brought about by atropin is notdependent on any action on the centers is shown by thefact that when instilled into one eye it causes dilata¬tion of the corresponding pupil without affecting the
other. Since after application to the eye the atropin
would be able to reach the. centers only by being ab¬
sorbed, and carried there through the general circula¬
tion, as after any other method of exhibition, it would
necessarily be carried equally to both centers, and we
would get a bilateral instead of a unilateral widening
of the pupil. Further, Claude Bernard has found the
mydriasis to occur in animals after section of the oculo¬
motor, and H. C. Wood has seen it in man, both in
cases of paralysis of the oculomotor nerve and of the
sympathetic nerve, and, moreover, a number of ob¬
servers have obtained dilatation of the pupil by atropin
even when the eye has been completely removed fromthe orbit.
The drug, therefore, affects the pupil peripherally,that is, the dilatation is due to either an action on a
portion of the nerve beyond the ganglia or else an effect
on the muscle. Bernstein and Dogiel found that elec¬
trical stimulation of the oculomotor nerve in cases of
atropin mydriasis had no effect on the pupil, indicating
again a peripheral palsy, but that when the electrodes
were applied directly to the sphincter fibers of the iris
the pupil was narrowed, showing that the muscle itself
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had not lost the power of responding to stimulation.
The dilatation, therefore, must be due to an action on
the peripheral ends of the nerves.
The question as to whether the oculomotor nerve is
paralyzed or the sympathetic stimulated is less easily
answered. The fact that stimulation of the oculomotor
fails to affect the atropinized pupil shows that this nerve
is paralyzed; but whether or not the sympathetic is at
the same time stimulated is a matter of some dispute.
The fact that stimulation of the sympathetic, either
electrically or by means of other drugs, such as cocain,
is able to still more widely dilate the atropinized pupil,
is brought forward as evidence that the sympathetic
fibers are not stimulated by the drug. This, however,
is by no means positive proof, for it is perfectly plaus¬
ible to suppose that although atropin might have a
stimulating effect-on the sympathetic fibers, other meas¬
ures could eause a still greater stimulation of these
same fibers. It would be as logical to reason that be¬
cause the combination of strychnin and atropin gives a
greater increase in the respiratory movement than atro¬
pin alone that therefore atropin does not stimulate the
respiratory center, as to reason that the sympathetic is
not affected by atropin on the evidence given above.
Clinical experience in cases of adhesions within the
eye shows that the dilatation of the pupil which occurs
under atropin is more than a merely passive one, because
it has force enough to frequently break up these ad¬
hesions. More than this, it has been found that when
the eye has been completely separated from the body
atropin is capable of causing dilatation of the pupil;
and since in the removal of the eye the oculomotor
nerve is entirely destroyed the further dilatation must
be due either to a stimulation of the sympathetic term¬
inals or a selective action on the radial muscles of the
iris, which action is extremely improbable. We must
conclude, therefore, that atropin dilates the pupil by
paralyzing the peripheral end of the oculomotor nerve,
and at the same time stimulating the terminations of
the sympathetic.
Spinal Cord.—The effect of atropin on the higher
nerve centers is a very complex one, and understood
but very imperfectly. In the first place, every one
knows that, a large dose of atropin has some peculiar
action on the brain, causing a wild delirium. Our
knowledge of the brain, however, is not sufficient to
allow us to determine more exactly the causes of this
delirium.
Coming to the spinal changes, we note that although
we find several theories to explain the effects of atro¬
pin on the spinal cord, our information is, after all,
hardly definite enough to be called knowledge. To dis¬
miss the question, as does one prominent text-book,
with the remark that atropin affects the spinal cord
like strychnin, not only avoids a perplexing problem, but
is also a very inaccurate statement, for although there
is, under the influence of atropin in the lower animals, a
secondary stimulation of the spinal cord, more or less re¬
sembling a mild case of strychnin poisoning, the pri¬
mary action of this drug on the reflex centers is
widely different from that of strychnin. As was first
discovered by Fraser, this early excitation is followed
in the frog by a palsy so complete that in his earlier
experiments Fraser thought the animal dead. Later,
however, he showed that there was not only a return,
but even a very distinct excitation of the reflexes. In
other words, that atropin causes the following sequence
of events : lessening of reflex activity, followed by paraly-
sis, and followed again by excitement. Since phar¬
macology gives no instance of a drug which produces
an exaltation of function after a primary depression,
it is evident that atropin affects something more than
merely the motor cells in the spinal cord. Fraser ex¬
plained the series of phenomena by supposing that the
spinal cord was excited from the beginning, but that
in the early stage there was a paralysis of the motor
nerves which prevented any impulses reaching the
muscles; and that this paralysis of the motor nerves
passed off more rapidly than the stimulation of the
spinal cord, causing the appearance of the symptoms of
excitation. Although it is true that a sufficient dose
of atropin will paralyze the motor nerves in a frog,
Ringer and Murrell have shown that protecting the
nerve from the action of the poison by ligating the
artery supplying it does not prevent the development
of the paralysis, and that consequently the palsy is not
dependent on any action either on the nerve or muscle.
Moreover, in my own experiments, I have found that
the time consumed in the spinal cord for the fulfilment
of the reflex act is distinctly prolonged by atropin, in¬
dicating a lessening in the functional activity in the
spinal centers.
The most plausible explanation of this peculiar se¬
quence of events is that based on the supposition of the
existence of a' spinal inhibitory center. Of course, this
is no time to discuss the truth or falsity of Setschenow's
theory of spinal inhibition; suffice it to say that there
are a number of pharmacologie facts inexplicable on any
other hypothesis. We know that atropin paralyzes in¬
hibition in the heart, and we know that atropin par¬
alyzes inhibition in the intestinal tract, and it is only
reasonable to suppose that it might also paralyze spinal
inhibition. With the acceptance of this theory the ex¬
planation of the spinal action of atropin becomes a
matter of comparative simplicity : there is first a
paralysis of the spinal cord and also a paralysis of
Setschenow's inhibitory centers. The paralysis of the
motor cells does not last as long as the inhibitory de¬
pression, so that as the reflex centers of the cord regain
their power the normal restraint is lacking and we have
as the result a combination of abnormally exaggerated
reflexes with muscular weakness.
Circulation.—The effect of atropin on the circula¬
tion is so well known that I shall dismiss it with but a
few words.
Under the influence of the moderate dose of atropin
there is a marked elevation of the blood pressure, ac¬
companied by a very pronounced increase in the fre¬
quency of the pulse. The rise of blood pressure is due
certainly in part to the increased heart action resulting
from vagai palsy, but chiefly perhaps to the narrowing
of the blood vessels. This is demonstrated by the fact
that after previous section of the pneumogastric nerve
atropin is capable of still elevating the blood pressure;
and since after section of these nerves atropin has no
effect on the pulse rate, the rise must be due to vaso¬
motor stimulation. Furthermore, it has been shown
that the drug is incapable of causing any considerable
rise in the pressure after section of the spinal cord, that
is, after destruction of thé vasomotor centers ; proof
positive that the drug has a direct stimulating influ¬
ence on the centers in the medulla controlling the blood
vessels.
The increase in the work of the heart is due chiefly
to the excessive rapidity of the pulse, which is de¬
pendent on removal of inhibitory restraint. That the
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increased rate of the pulse is due to paralysis of thepneumogastric nerve is clearly proven by three facts :First, in those animals whose pneumogastric nerves are
not in a state of tonic activity, as the rabbit, for ex¬
ample, atropin has little effect on the pulse rate ; second,
in those animals which, like man, have active inhibition,
if the pneumogastric nerve is divided atropin is incap¬
able of causing any distinct increase in the rate of the
pulse; and, finally, electrical stimulation of the atro¬pinized vagus does not slow the pulse.
It is probable, however, that the minute dose of atro¬pin has a certain amount of stimulant influence directly
on the cardiac muscle, for Beyer has found that the
isolated heart of the terrapin is stimulated by small
quantities of the alkaloid, and Langendorff brings evi¬
dence to show a similar effect on the frog's heart.
With this very cursory glance at some of the more
prominent points concerning the physiologic action of
atropin and hyoscyamin, we pass to the consideration of
our second group.
HYOSCIN" AND SCOPOLAMIN.
When we start to discuss the physiologic action of
hyoscin, or rather before we start, we open a question
on which there is so much disagreement that we can
hardly claim to have any definite knowledge; indeed,
even the existence of hyoscin is frequently denied, it
being by many authorities considered to be identical
with scopolamin. There seems to be but little doubt
that in the majority of cases the substance sold under
the name of hyoscin is in reality scopolamin; and there
is certainly justification for the German Pharmacopeia
in substituting for the name hyoscin the term scop¬
olamin. Nevertheless, I am one of those who believe
that there are two solanaceous alkaloids similar in their
physiologic effects, and yet different enough to allowdistinction, which have been known under the names
of hyoscin and scopolamin. Both substances have, un¬fortunately, been called hyoscin, and as the true hyoscin
seems not at present to be extant in commerce, what is
to-day employed under the name of hyoscin is in reality
scopolamin.
It is noteworthy in this connection that when Schmidt
first asserted the identity of commercial hyoscin with
the alkaloid scopolamin, he did not deny that the sub¬
stance described by Landenberg might have been some¬
thing else, and it is certainly taking a great many lib¬
erties with the work of an authority so well known asLandenberg to assert that his descriptions, both of theformula and of the properties of his discovery, were in¬
correct. There is both chemical and physiologic evi¬dence of the separate identity of these two alkaloids.
Hesse has shown that certain specimens of scopola¬
min contain a substance with an optical rotary power
muscle inferior to that of scopolamin itself. Louis
Merck has brought confirmatory evidence to this dis¬
covery of Hesse's, in that he found that whereas the
hyoscin prepared from hyoscyamus had an optical rotary
power of 25 degrees, that from Scopolia atropoid.es had '
at times as low as 13.5 degrees; suggesting that in one
or the other of them there was some other alkaloid which
changed the effect of this substance on the rays of light.Leaving out the chemical evidence we find that the
physiologic evidence that there are two narcotic alka¬
loids belonging to the tropin series is sufficiently con¬
vincing. As far as I have been able to find, there have
been but three careful complete researches on the action
of hyoscin: those of Clausen, of Kobert and of H. C.
Wood. All of these authors are in accord that hyoscin
differs distinctly from atropin. For example, they all
agree that it is not an excitant to the spinal cord; they
agree that it is a somnifacient, although they are not
unanimous concerning the power of its hypnotic action.
It is interesting, however, to find that whereas the earlier
researches, those of Clausen and Wood, showed through¬
out a fair degree of similarity, the later researches of
Kobert differ quite widely from them in many respects.
Thus, Clausen and Wood both found that the pulse was
slowed by hyoscin in marked contrast to the effect of
atropin ; but Kobert, with full knowledge of the results
of these investigators, and presumably exercising there¬
fore even more than ordinary care, found that hyoscin
affected the pulse precisely as did atropin, producing the
same paralysis of terminal ends of the vagus. Moreover,
whereas Wood found that comparatively small quanti¬
ties of the alkaloid were distinctly depressant to the
respiration, Kobert failed to obtain any lessening in the
breathing, even with enormous doses. It is hardly pos¬
sible that into the investigations of an experimenter
of such ability as Professor Kobert, especially working
as he did with knowledge of previous contrary results,
there could have entered sufficient error to explain the
differences of his results and those of the previous in¬
vestigators; and it is equally illogical to suppose that
the results of Clausen and Wood, one made in Europe
and the other in America, at least one of the investi¬
gators being an acknowledged authority, would agree
so closely in their results unless they had both been sub¬
stantially correct. In the face of such contradiction the
conclusion seems to me inevitable that Kobert had a
different substance from that with which Wood and
Clausen were working.
The clinical evidence of the separate identity of these
two substances is also worthy of consideration. Both
Wood and Kobert experimented on human beings con¬
cerning the effect of these substances on the brain; but
whereas Kobert found that it was a comparatively feeblehypnotic, useful in only a minority of cases, Wood came
to the conclusion that it was a hypnotic of considerable
power. Every physician who has used hyoscin to any
extent has noticed a very marked irregularity in its
somnifacient action. At times it will seem to deserve
a place among our most certain narcotics; on other
occasions it will produce a condition more closely allied
to the atropin delirium than to sleep. I myself believe
that these differences can be most easily explained by
the supposition that we are dealing with different sub¬
stances.
In view of our ignorance concerning the identity ofhyoscin and the dispute concerning its physiologic
action, it is hardly possible to give in detail the physio¬
logic action of hyoscin. In order, however, to consider
the question of the action of mydriatic alkaloids in all
its bearings, I shall very briefly point out the differences
between atropin on the one hand and hyoscin as de¬
scribed by Wood and hyoscin as described by Kobert on
the other.
It will be remembered that atropin is a powerful
vasomotor stimulant; hyoscin, on the other hand, ac¬
cording to both the authorities quoted, exercises at no
time any stimulant effect on the blood pressure. Ac¬
cording to Kobert even enormous quantities have abso¬
lutely no effect on the blood pressure; but according to
Wood, if the dose is large enough there is some weaken¬ing of the vasomotor centers. On the pulse rate Wood
has found that hyoscin has not a great deal of effect,
but tends somewhat to slow the pulse. On the other
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hand, Kobert has found that the alkaloid overcomes
the inhibitory stimulation of muscarin, and produces
in the dog and in man an atropin-like paralysis of in¬
hibition with consequent rapidity of the pulse.
Another difference between the actions of atropin
and hyoscin is in their effect on the higher nerve centers.
All authorities agree that under hyoscin there is lack¬
ing the primary stimulant influence of the central
nervous system characteristic of atropin. According to
Kobert. with the exception of the brain, hyoscin has no
effect on the nervous system. On the other hand, Wood
has found that hyoscin is distinctly depressant, not
only to the brain, but also to the respiratory centers and
to the motor side of the spinal cord.
In this very brief summary of some of the more vital
points concerning the pharmacologie relations of the
solanaceous alkaloids I have endeavored to present as
fairly as possible the true state of our information, not
attempting to hide our ignorance under the cloak of any
unproven theory however ingenious and attractive it
may be. It is painfully evident that there are many
gaps in our knowledge of these principles ; "gaps which
unfortunately limit their usefulness as practical rem¬
edies. The helplessness of the clinician to supply this
lack in our knowledge is but another evidence of the
value to practical medicine of scientific research. Until
the scientist shall have demonstrated beyond cavil the
chemical identity and the physiologic properties of these
alkaloids, the practical physician, unable to know cer¬
tainly what he is giving, can not expect to obtain definite
therapeutic results from their use. And yet, many of
these alkaloids seem to possess virtues which would
make them extremely valuable to the physician if more
clearly understood, and there is to-day as urgent need_
of careful scientific study of the mydriatic alkaloids as
perhaps of any other group of drugs which are em¬ployed for the purpose of alleviating human suffering.
THE MYDRIATIC DRUGS AND THEIE ACTIVE
PRINCIPLES.
THE OPHTHALMOLOGIC RELATIONS.*
CHARLES A. OLIVER, A.M., M.D.
PHILADELPHIA.
The drugs spoken of as mydriatics are ophthalmolog-
ically divisible into four classes—analgesics, mydriatics,
iridoplegics and cycloplegics. They receive their generic
name from the most prominent objective sign that is pro¬duced by their action. By reason of their many-sided
effects they are the most valuable diagnostic and thera¬
peutic agents which are employed in ophthalmic prac¬
tice, the effects being mainly dependent on varyinggrades of true peripheral palsy.
They always act locally. This has been proven by the
application of mydriatic-containing aqueous humors toother eyes, and by the action of the drugs after excision
of the heart, after decapitation and after isolation of the
eyeball. Further proof of their local action is shown
by their increased activity after removal of the externallayers of the cornea. Moreover, local applications never
affect the fellow organ in a similar way.
Most prominent among the mydriatic agents are:
holocain, cocain, eucain, euphthalmin, homatropin, my-drin, atropin, scopolamin, daturin, hyoscyamin. hyoscin
and duboisin.1 As is well known, many of these alka¬
loids, although differing by but one or two elemental
atoms each, or even when absolutely isomerie, have
variable physiologic actions on one andthe same seriesof
ocular structures. So, too, with the supposedly identical
alkaloids derived from the same genus of plants grown
in various countries, undeT varying conditions, or when
obtained from one and the same plant at different ages.
These peculiarities of action are probably dependent on
idiosyncrasies of molecular arrangement of the same
number of contained elements, the relative optimal and
subinvolutional conditions of the contained cell-forms,
and the variability of the ocular structures.
The only true method of differentiating these effects
and grading the relative degrees of therapeutic useful¬
ness of the drugs is to study their comparative powers on
the excessively rare normal emmetropie eye or on the
carefully corrected and healthy ametropic organ ; a plan
which gives a series of known factors on which to base
desired effects on irritated, inflamed, and at times, weak¬
ened tissues.2
The chief effects of this class of therapeutic agents on
the eye consist in external and internal analgesias com¬
bined with local paralyses of the sphincter muscles of
the iris and ciliary body. By some observers most of the
drugs (particularly atropin, daturin, scopolamin, hyos¬
cyamin and duboisin) are supposed to exert simul¬
taneous excitatory actions on the radiary fibers of the
iris and the ciliary body. Some of the drugs are said to
contract the blood vessels and to act on the peripheral
ends of the nerves. A number of authorities believe that
cocain-, holocain- and eucain-mydriases are due to local
irritation of the sympathetic nerve endings in the iris(both vasoconstrictor and p*ipil-inhibitory fibers).
The local effects of the drugs· are increased by bodily
rest, \vith non-usage and non-exposure of the ocular or¬
gans. Cold applications diminish both the primary and
secondary actions of the drugs. Heat tends to promote
both of these results.
While the drugs are in use, colored glasses—prefer¬
ably smoke-tinted coquilles which are free from blem¬
ishes and optical imperfections—should be worn. The
degree of tinting should be regulated by the feelings ofthe patient and the conditions of the case. All of the
solutions should be freshly prepared in small quantities,
made neutral and kept only for brief periods of time.Some ophthalmologists prefer to add boric acid or
some preservative to the solutions, but this is
not necessary if the above rules are followed.
During the instillation of the drugs care should be taken
to prevent their passage into the lacrymal and the nasal
passages.
The drugs which are employed for the definite and
determinate purpose of pure mydriasis in ophthalmology
are comparatively few. In the writer's hands they arelimited in the order of their relative values to the fol¬
lowing : euphthalmin, homatropin. mydrin and ephedrin.Used in the strict sense of the term they serve an im-
* This abstract of the original paper, read at the Fifty-thirdAnnual Meeting of the American Medical Association, in the Sec-tion on Materia Medica, Pharmacy and Therapeutics, is approvedfor publication by the Executive Committee: Drs. A. W. Baer, A.B. Lyons and W. J. Robinson.
1. Several other less frequently employed alkaloids, delphinin,
solanin, etc., are not considered here. A number of experimentswith the biborate and the salicylate of solanin have been conductedby the writer, but the results are reserved for a paper on another
subject. The writer has not considered drugs, such as gelseminin,
coninin, aconitin, which produce local effects on the eyeballs andtheir related structures by ingestion and topical application else-
where, even when they are thus intended; for example, the inter-
nal administration of hyoscyamin for spastic conditions of theinterior and exterior ocular muscles. Such drugs as strychnin and
curare also have not been considered.
2. In the tests which have been conducted by the writer simi-lar conditions in regard to illumination, time of day, condition of
eyes, form of apparatus, and choice and use of drugs have been
maintained.
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